Table 1.
Comparison of demographic and clinical data between controls and first-episode drug naïve patients with SCZ.
| Variables | Controls | SCZ | χ 2/t (P) |
|---|---|---|---|
| Sex (female/male) | 22/14 | 54/25 | 0.579 (0.447) |
| Age (years) | 28.11 ± 5.16 | 34.39 ± 11.85 | 3.045 (0.003) |
| BMI (kg/m2) | 22.60 ± 2.96 | 23.46 ± 4.25 | 1.101 (0.273) |
| BPRS | - | 48.70 ± 9.55 | - |
| Anxiety depression | - | 5.51 ± 2.03 | - |
| Thought disturbance | - | 11.05 ± 2.88 | - |
| Anergia | - | 9.91 ± 2.83 | - |
| Activation | - | 4.73 ± 2.13 | - |
| Hostile suspiciousness | - | 9.28 ± 3.32 | - |
| PANSS | - | 86.91 ± 16.63 | - |
| Positive symptom | - | 11.73 ± 3.82 | - |
| Negative symptom | - | 20.20 ± 6.27 | - |
| Cognitive defect | - | 9.89 ± 2.97 | - |
| Excited symptom | - | 11.69 ± 3.95 | - |
| Depressive symptom | - | 4.05 ± 1.39 | - |
BMI, Body mass index; BPRS, Brief Psychiatric Rating Scale; PANSS, Positive and Negative Syndrome Scale; SCZ, schizophrenia.